Real-World HRU and Costs in DLBCL Pts With Tisa-cel and Axi-cel, a Medicare Study.
Clinical trial NCT06271369 · COMPLETED
Trial details
- NCT number
- NCT06271369
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-11
- Primary completion
- 2023-02-15
- Enrollment
- 613
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.